Publications

Warren Shlomchik

Kim TK, DeVeaux M, Stahl M, Perreault S, Isufi I, Cooper D, Foss F, Shlomchik W, Zelterman D, Zeidan AM, Seropian S. Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation. Ann Hematol. 2019 Jan;98(1):237-240. doi: 10.1007/s00277-018-3427-1. PubMed PMID: 30027436.
Agle K, Vincent BG, Piper C, Belle L, Zhou V, Shlomchik W, Serody JS, Drobyski WR. Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD. Blood. 2018 Jul 26;132(4):435-447. doi: 10.1182/blood-2017-09-807156. PubMed PMID: 29769260; PMCID: PMC6071561.
Dai H, Friday AJ, Abou-Daya KI, Williams AL, Mortin-Toth S, Nicotra ML, Rothstein DM, Shlomchik WD, Matozaki T, Isenberg JS, Oberbarnscheidt MH, Danska JS, Lakkis FG. Donor SIRPα polymorphism modulates the innate immune response to allogeneic grafts. Sci Immunol. 2017 Jun 23;2(12): doi: 10.1126/sciimmunol.aam6202. PubMed PMID: 28783664; PMCID: PMC5653256.
Matte-Martone C, Liu J, Zhou M, Chikina M, Green DR, Harty JT, Shlomchik WD. Differential requirements for myeloid leukemia IFN-γ conditioning determine graft-versus-leukemia resistance and sensitivity. J Clin Invest. 2017 Jun 30;127(7):2765-2776. doi: 10.1172/JCI85736. PubMed PMID: 28604385; PMCID: PMC5490746.
Mohammed J, Beura LK, Bobr A, Astry B, Chicoine B, Kashem SW, Welty NE, Igyártó BZ, Wijeyesinghe S, Thompson EA, Matte C, Bartholin L, Kaplan A, Sheppard D, Bridges AG, Shlomchik WD, Masopust D, Kaplan DH. Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-β. Nat Immunol. 2016 Apr;17(4):414-21. doi: 10.1038/ni.3396. PubMed PMID: 26901152; PMCID: PMC5135085.

<< Investigators Search

Top